Endovascular Interventions for Venous Disease

Area of Science:

• Vascular Medicine
• Interventional Cardiology
• Thrombosis Research

Background:

• Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, affects up to 900,000 individuals annually in the U.S.
• Current standard treatment, systemic anticoagulation, has limitations, with nearly 40% of cases showing thrombus propagation and failing to alleviate acute symptoms or prevent postthrombotic syndrome.
• There is a recognized unmet need in managing venous disease, driving the development of advanced treatment modalities.

Purpose of the Study:

• To review the current landscape of venous thromboembolism treatment.
• To discuss the emerging role and clinical utility of endovascular therapies for venous disease.
• To analyze the advantages and disadvantages of minimally invasive endovascular interventions.

Main Methods:

• Literature review of endovascular techniques for venous thromboembolism.
• Comparative analysis of anticoagulation versus endovascular approaches.
• Discussion of catheter-directed thrombolysis, mechanical thrombectomy, and pharmacomechanical catheter-directed thrombolysis.

Main Results:

• Anticoagulation alone demonstrates suboptimal efficacy in preventing thrombus propagation and symptom resolution.
• Endovascular therapies provide minimally invasive options for active thrombus removal.
• These interventions aim to reduce complications and mitigate the inflammatory response associated with VTE.

Conclusions:

• Endovascular therapies represent a significant advancement in managing venous thromboembolism.
• These minimally invasive techniques offer potential benefits over traditional anticoagulation, including active clot removal and symptom relief.
• Further research and clinical evaluation are essential to fully establish the role of endovascular interventions in venous disease management.